CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer

Jenny Harris, Vicki Tsianakas, Emma Ream, Mieke Van Hemelrijck, Anand David Purushotham, Lorelei Mucci, James Green, Karen Robb, Jacquetta Fewster, Jo Armes

Research output: Other contribution

1 Citation (Scopus)

Abstract

Increasing numbers of people in the UK are living with recurrent or metastatic cancer, many of whom experience reduced quality of life resulting from the physical and psychosocial consequences of cancer and its treatment. While drug treatments are important at alleviating some symptoms, there is increasing evidence of the benefits of exercise in enhancing quality of life and health outcomes. Walking is an inexpensive and accessible form of exercise. To our knowledge, no studies have investigated whether a walking intervention is sufficient to enhance quality of life and alleviate symptoms in people with recurrent or metastatic cancer across a range of tumor types. This paper describes the CanWalk study protocol, which aims to assess the feasibility and acceptability of undertaking a randomized controlled trial of a community-based walking program to enhance quality of life and well-being in people with recurrent or metastatic cancer.
Original languageEnglish
TypeStudy Protocol
PublisherBioMed Central
Number of pages7
Volume1
DOIs
Publication statusPublished - 12 Mar 2015

Fingerprint

Dive into the research topics of 'CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer'. Together they form a unique fingerprint.

Cite this